Cooperative Agreement U01DP006933
Award Date 9/30/26
Completion Date 9/29/30
Dollars Obligated $498K
Funding Federal Agency
Awarding Federal Agency
Federal Grant Program
Assistance Type
Cooperative Agreement
Place of Performance
Philadelphia, PA, USA
Similar Awards
- The National Institute of Child Health and Human Development awarded The Children's Hospital of Philadelphia $356,000 on May 15, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to analyze disease trajectories of rare genomic variants contributing to childhood lesional brain disorders and epilepsies. The recipient will integrate genomic sequencing data from two Kids First cohorts—one focused on epilepsy and one on brain tumors—with longitudinal...
- The Centers for Disease Control and Prevention awarded Weill Medical College of Cornell University a $499,756 Cooperative Agreement on September 30, 2026, to support CEPIE (Collaboration to Estimate the Pediatric Incidence of Epilepsy), a CDC Investigations and Technical Assistance program under CFDA 93.283. The award funds activities through September 29, 2030, with place of performance in New York, New York. The program aims to assist state and local health authorities and other health...
- The National Institute of Child Health and Human Development awarded The Children's Hospital of Philadelphia $248,999 on September 2, 2026, under the Child Health and Human Development Extramural Research Projects program (CFDA 93.865). The award funds research training to develop expertise in emotional and biobehavioral mechanisms of parent-infant emotional synchrony. The principal investigator will pursue advanced training in mother-infant electrocardiogram and electroencephalography...
- The National Institute of Neurological Disorders and Stroke awarded The Children's Hospital of Philadelphia $219,658 on May 19, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to validate wearable magnetoencephalography (MEG) technology for presurgical language mapping in pediatric epilepsy patients. The project develops and tests a wearable MEG array based on optically pumped magnetometer (OPM) technology that does not require...
- The National Institute of Child Health and Human Development awarded $765,377 to The Children's Hospital of Philadelphia on June 17, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to establish clinical trial readiness of magnetoencephalography (MEG) biomarkers in children across the autism spectrum. The award funds a 12-week repeated scanning design study to standardize and validate two leading MEG measures—diminished and delayed auditory evoked...
- The National Institute of Allergy and Infectious Diseases awarded The Children's Hospital of Philadelphia $849,915 on August 17, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to develop mass spectrometry technologies that map post-translational modification (PTM) enzyme-substrate networks during infections. The project will create a suite of proteomics methods to directly connect PTM enzymes to their substrates and modification sites, addressing a critical gap in...
- The Centers for Disease Control and Prevention awarded a $418,550 Cooperative Agreement to Massachusetts General Hospital on September 30, 2026, to advance understanding of pediatric epilepsy incidence and risk factors through a multilevel population health approach under the CDC Investigations and Technical Assistance program (CFDA 93.283). The award funds research activity performed at MGH's Research Management Division in Boston, Massachusetts, with a period of performance extending through...
- The Defense Health Agency awarded The Children's Hospital of Philadelphia $1,118,257 on September 1, 2026, under the Military Medical Research and Development program (CFDA 12.420) to build the Child and Adolescent Thyroid Consortium. The award funds research infrastructure and consortium coordination activities at the Children's Hospital of Philadelphia Research Institute in Philadelphia, Pennsylvania, with a period of performance through August 31, 2029. The Military Medical Research and...
- The Centers for Disease Control and Prevention awarded a $685,812 Cooperative Agreement to Public Health Management Corporation on September 30, 2025, to evaluate the impact of a publicly funded partial hospitalization program in reducing overdose risk in Philadelphia under the Injury Prevention and Control Research and State and Community Based Programs (CFDA 93.136). Public Health Management Corporation, doing business as The Philadelphia Health Management, is a tax-exempt nonprofit health and...
- The Defense Health Agency awarded $1,749,980 to The Children's Hospital of Philadelphia on September 1, 2026, to investigate mechanisms of efficacy and toxicity following adeno-associated virus gene therapy for Duchenne muscular dystrophy. The award, made under the Military Medical Research and Development program (CFDA 12.420), runs through August 31, 2030, with work performed in Philadelphia, PA. The Children's Hospital of Philadelphia Research Institute, operating as Children's Hospital of...